Literature DB >> 9421455

Time course of cerebral edema after traumatic brain injury in rats: effects of riluzole and mannitol.

F Bareyre1, F Wahl, T K McIntosh, J M Stutzmann.   

Abstract

Brain trauma is the main cause of morbidity and mortality in young adults. One delayed events that occurs after a head trauma and compromises the survival of patients is cerebral edema. The present study examined first the occurrence of cerebral edema after a traumatic brain injury (TBI) induced by moderate fluid percussion in rats. Brain water content was measured from 1 h to 7 days posttrauma, in the hippocampus and cortex, on both ipsi- and contralateral hemispheres. Second, the effects of mannitol, an osmotic agent frequently used in the clinic, and riluzole, a neuroprotective compound, were investigated on regional edema formation. After TBI, the ipsilateral edema began early at 1-6 h, was maximal at 48 h and was resorbed by 5-7 days. No edema was observed in the contralateral hemisphere. Mannitol at 1 g/kg or vehicle was administered iv 15 min, 2 h and 4 h postinjury. At this dose, mannitol significantly attenuated the ipsilateral injured cortex edema measured at 6 h (p < 0.05). Riluzole at 4 and 8 mg/kg or vehicle was administered 15 min (IV) and 6 h, 24 h, and 30 h (SC) post-TBI. Riluzole at 4 x 4 mg/kg significantly reduced edema measured at 48 h, in the ipsilateral hippocampus (p < 0.05), whereas at 4 x 8 mg/kg, the reduction was observed in the hippocampus (p < 0.01) and the injured cortex (p < 0.05). Our results demonstrate that (1) cerebral edema begins early after the injury and is resorbed over 1 week; (2) mannitol could attenuate cerebral edema; and (iii) riluzole in addition to its neuroprotective effects reduces the brain edema. Thus, riluzole could be useful in human TBI treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9421455     DOI: 10.1089/neu.1997.14.839

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  23 in total

1.  Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children.

Authors:  George P Liao; Matthew T Harting; Robert A Hetz; Peter A Walker; Shinil K Shah; Christopher J Corkins; Travis G Hughes; Fernando Jimenez; Steven C Kosmach; Mary-Clare Day; KuoJen Tsao; Dean A Lee; Laura L Worth; James E Baumgartner; Charles S Cox
Journal:  Pediatr Crit Care Med       Date:  2015-03       Impact factor: 3.624

Review 2.  Evidence-based review of oral traditional Chinese medicine compound recipe administration for treating weight drop-induced experimental traumatic brain injury.

Authors:  Bo Yang; Zhe Wang; Chenxia Sheng; Yang Wang; Jing Zhou; Xin-gui Xiong; Weijun Peng
Journal:  BMC Complement Altern Med       Date:  2016-03-09       Impact factor: 3.659

Review 3.  Dealing with Danger in the CNS: The Response of the Immune System to Injury.

Authors:  Sachin P Gadani; James T Walsh; John R Lukens; Jonathan Kipnis
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

4.  Transient aphasias after left hemisphere resective surgery.

Authors:  Stephen M Wilson; Daniel Lam; Miranda C Babiak; David W Perry; Tina Shih; Christopher P Hess; Mitchel S Berger; Edward F Chang
Journal:  J Neurosurg       Date:  2015-06-26       Impact factor: 5.115

5.  Progenitor cells: therapeutic targets after traumatic brain injury.

Authors:  Robert A Hetz; Supinder S Bedi; Scott Olson; Alex Olsen; Charles S Cox
Journal:  Transl Stroke Res       Date:  2012-05-22       Impact factor: 6.829

Review 6.  Riluzole in the treatment of mood and anxiety disorders.

Authors:  Christopher Pittenger; Vladimir Coric; Mounira Banasr; Michael Bloch; John H Krystal; Gerard Sanacora
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

7.  The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury.

Authors:  Carrie A Keck; Hilaire J Thompson; Asla Pitkänen; David G LeBold; Diego M Morales; Jamie B Plevy; Rishi Puri; Boyu Zhao; Marc Dichter; Tracy K McIntosh
Journal:  Restor Neurol Neurosci       Date:  2007       Impact factor: 2.406

8.  Preventing neuronal edema increases network excitability after traumatic brain injury.

Authors:  Punam A Sawant-Pokam; Tyler J Vail; Cameron S Metcalf; Jamie L Maguire; Thomas O McKean; Nick O McKean; K C Brennan
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

9.  Autologous bone marrow mononuclear cells therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury.

Authors:  Supinder S Bedi; Peter A Walker; Shinil K Shah; Fernando Jimenez; Chelsea P Thomas; Philippa Smith; Robert A Hetz; Hasen Xue; Shibani Pati; Pramod K Dash; Charles S Cox
Journal:  J Trauma Acute Care Surg       Date:  2013-09       Impact factor: 3.313

10.  Beneficial effects of hyperbaric oxygen on edema in rat hippocampus following traumatic brain injury.

Authors:  Su Liu; Ying Liu; Shukun Deng; Aisong Guo; Xiubing Wang; Guangyu Shen
Journal:  Exp Brain Res       Date:  2015-08-13       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.